The upregulation of CDH1 reduced the activity of the Wnt/β-catenin signaling pathway, which in turn affected the stem cell properties of NSCLC cells, and in clinical analysis, patients with increased miR-708-5p expression had significantly higher survival and lower recurrence rates. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.